We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Structural Biology Helps Drive Coronavirus Vaccine Development

News   Mar 03, 2020 | Original story from the NIH Director’s Blog

 
Structural Biology Helps Drive Coronavirus Vaccine Development

This scanning electron microscope image shows SARS-CoV-2 (magenta) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S. Credit: NIAID-RML

 
 
Advertisement
 

RELATED ARTICLES

Historical Bias Overlooks Genes That Are Related to COVID-19

News

Based on genome-wide experiments, the human body has 2,064 genes relevant to COVID-19. So why are researchers only studying 611 of them?

READ MORE

Key Questions and Answers About the UK's First Approved COVID-19 Vaccine

News

The UK government has announced that the COVID-19 vaccine BNT162b2 – developed by Pfizer and BioNTech – has been authorized for use. Here, we address some of the key questions you may have about this announcement.

READ MORE

Why Proteins Clump in Neurodegenerative Disease

News

New research has resulted in a better understanding of the formation of large amounts of tau protein, which is a key protein involved in many neurodegenerative diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE